Colchicine binding site-targeting microtubule inhibitor therapy(BridGene Biosciences/University of Tennessee)
N/A
Report date: 2024/01/03 15:38:55
Base Information
Drug NameColchicine binding site-targeting microtubule inhibitor therapy(BridGene Biosciences/University of Tennessee)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBridGene Biosciences IncThe University Of Tennessee
China Registration ClassN/A
Develop Information
Active CompaniesThe University Of TennesseeBridGene Biosciences Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A